A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis
Clinical trial NCT01610596 · COMPLETED
Trial details
- NCT number
- NCT01610596
- Sponsor
- Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2012-02-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.